Celyad Oncology
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology,
Celyad Oncology has raised €29M across 1 funding round from 1 investor, most recently a round in Dec 2021. Based in Walloon, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Walloon, Belgiumcelyad.com ↗
Total raised
€29M
€28,794,188
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearCelyad Oncology — funding by year — interactive chart.
Data table
| Celyad Oncology — funding by year | |
|---|---|
| 2021 | €29M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-06 | Other | €29M | Fortress Investment Group | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData